1-8 of 8
Jennifer L Byrne
Close
Sort by
Journal Articles

Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?

Christof Scheid, Diderik-Jan Eikema, Michel Van Gelder, Urpu Salmenniemi, Johan Maertens, MD, Jakob R Passweg, Didier Blaise, Jennifer L Byrne, Nicolaus Kroeger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J. Cornelissen, Henrik Sengeloev, Jürgen Finke, John A. Snowden, Tobias Gedde-Dahl, jerôme cornillon, Urs Schanz, amit patel, Linda Koster, Liesbeth C. de Wreede, Patrick J Hayden, Kavita Raj, Joanna Drozd-Sokolowska, Carmelo Gurnari, Francesco Onida, Donal P McLornan, Marie Robin, Ibrahim Yakoub-Agha
Journal: Blood
Blood blood.2023022273.
https://doi.org/10.1182/blood.2023022273
Published: 2024
Includes: Supplemental data
Journal Articles

The Target UK Study: Real-World Evidence of Molecular Response to Tyrosine Kinase Inhibitors Supports European Leukemianet 2013 Recommendations for the Management of Chronic Myeloid Leukaemia

Dragana Milojkovic, MBBS, PhD, Richard E. Clark, Jennifer L Byrne, Brian J.P Huntly, Manoj Raghavan, Farooq A Wandroo, Sahra Ali, Belinda Austen, Jacqueline Ryan, Karsten Friedrich, Nicholas C.P. Cross, PhD, Adam J Mead, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2892.
https://doi.org/10.1182/blood.V130.Suppl_1.2892.2892
Published: 2017
Journal Articles

A Comparison of Stem Cell Source in Adult and Paediatric Recipients of T-Cell Depleted Myeloablative Transplants for Standard Risk Leukaemia: No Difference in Mortality Using BM or PBSC.

Bronwen E Shaw, Jane Apperley, Nigel H. Russell, MD, Charles F. Craddock, BM, MRCP, MRCPath, Effie Liakopoulou, Michael N Potter, Robert Wynn, MRCP, FRCPath, MD, Brenda ES Gibson, R. Pearce, Keiren Kirkland, Alejandro Madrigal, Gordon Cook, MD, PhD, Jennifer L Byrne, PhD
Journal: Blood
Blood (2009) 114 (22): 1205.
https://doi.org/10.1182/blood.V114.22.1205.1205
Published: 2009
Journal Articles

Reduced Intensity Allogeneic Transplantation Using BEAM-Alemtuzumab in Patients with Lymphoid Malignancy: Long Term Results and Impact of Intervention with DLI.

Emma P. Das-Gupta, DM, Jennifer L. Byrne, PhD, Charles Craddock, MD, Stephen Robinson, PhD, Stephen Devereux, MD, Antonio Pagliuca, MD, Grant McQuaker, DM, Andrew P. Haynes, DM, Ghulam Mufti, MD, Nigel H. Russell, MD
Journal: Blood
Blood (2005) 106 (11): 2890.
https://doi.org/10.1182/blood.V106.11.2890.2890
Published: 2005
Journal Articles

Combination Chemotherapy with Cyclophosphamide, Thalidomide and Dexamethasone Achieves a High Response Rate in Patients with Newly Diagnosed, VAD-Refractory and Relapsed Myeloma.

Catherine D. Williams, MD, Jennifer L. Byrne, MD, PhD, Gamal Sidra, MD, Sonya Zaman, MD, Nigel H. Russell, MD
Journal: Blood
Blood (2004) 104 (11): 1499.
https://doi.org/10.1182/blood.V104.11.1499.1499
Published: 2004
Journal Articles

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

Clinical Trials & Observations
Rowena D. Faulkner, Charles Craddock, Jennifer L. Byrne, Prem Mahendra, Andrew P. Haynes, Hugh G. Prentice, Michael Potter, Antonio Pagliuca, Aloysius Ho, Stephen Devereux, Grant McQuaker, Ghulam Mufti, John Liu Yin, Nigel H. Russell
Journal: Blood
Blood (2004) 103 (2): 428–434.
https://doi.org/10.1182/blood-2003-05-1406
Published: 2004
Journal Articles

CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath

Rowena D. Bainton, Jennifer L. Byrne, Barbara J. Davy, Nigel H. Russell
Journal: Blood
Blood (2002) 100 (10): 3843.
https://doi.org/10.1182/blood-2002-08-2398
Published: 2002
Journal Articles

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

Phennapha Klangsinsirikul, G. Ian Carter, Jennifer L. Byrne, Geoff Hale, Nigel H. Russell
Journal: Blood
Blood (2002) 99 (7): 2586–2591.
https://doi.org/10.1182/blood.V99.7.2586
Published: 2002